
دسبحان
سبحان دارو
Adjusted Price Chart of دسبحان and دسبحان Signal Trend
سود 3 Months :
Traders' comments on price دسبحان
Who made the most profit from دسبحان?
سیگنالهای دسبحان
Filter
Signal Type
Trader Type
Time Frame
نوع پیام

صندوق سرمایه گذاری قابل معامله بخشی کیان
The Kian Trading Investment Fund has sold 1.316 million shares on 14/05/05 and currently holds 1.268 % of Doshan's shares in its portfolio.

صندوق سرمایه گذاری قابل معامله بخشی کیان
Kian's tradable investment fund sold 1.316 million shares on 14/04/31 and currently holds 1.268 % of Doshan's shares in its portfolio.

مانا بورس
و Iran's injectable and pharmaceutical products in the spring, with the sale of 2 billion tomans, increased by 5 % over the same period last year. This growth, with the improvement of the profit margin, with a net profit of 2 billion tomans, was 2 percent. The net profit of the year was 2 billion tomans, which has been able to realize 2 % in one season in the spring of Dafra. According to the comparison between the June and spring sales report of this year and the same period last year and the winter season, symbols #Defra #Drug #Dalber #Caspian #Dabor #Danco #Danco and #Damidid, show the greatest monthly sales increase compared to their past times. #Dafra #Medicine 📱@Fardaname

بورس طارم
#Dischool 6 -month -old Miandore Information and Financial Statement (9/09/30) 6 months of net safety: 194.9 billion tomans increased by 511 percent compared to the previous year. The accumulated safety of 367.7 billion tomans increased by 103 percent compared to last year. Seasonal Profit: 367 Rials P / e: 6.74 P / O group: 9.04 Stock number: 10 billion Market value: 2,449 billion USD Support your shares by submitting this report on the channel and the stock exchange groups 🇮🇷@dndir

بورس طارم
و Iran's injectable and pharmaceutical products in the spring, with the sale of 2 billion tomans, increased by 5 % over the same period last year. This growth, with the improvement of the profit margin, with a net profit of 2 billion tomans, was 2 percent. The net profit of the year was 2 billion tomans, which has been able to realize 2 % in one season in the spring of Dafra. According to the comparison between the June and spring sales report of this year and the same period last year and the winter season, symbols #Defra #Drug #Dalber #Caspian #Dabor #Danco #Danco and #Damidid, show the greatest monthly sales increase compared to their past times. #Dafra #Medicine 📱@Fardaname

سهام کانسلیم | تحلیل و آموزش بورس
💡 #Spring_Community reports (2) 1404/04/29 ✅ #Wow, a report! Spring 24 Tomans, 294% more than last year PE ~ 6.7, price 428 USD ▫️ Excellent and expected. Only deposit profits were a little better than expected, making the report even a little better than expectations. # #Sarab was great and spring 211 Tomans, 116% more than last year PE ~ 5.7, priced at 4025 Tomans ▫️ About 40% of the profit from the subsidiary's dividends is identified each spring. # #Fame continued its good performance and made 41 Tomans spring, 79% more than last year PE ~ 5, price 700 USD ✅ #Medication that has been transformed and we said a lot of monthly reports, it had a great spring and made 160 tomans, 388% more than last year PE ~ 7.1, price of 2386 USD ▫️ The profit margin repeated 43% of the winter and this report was directly the result of the company's operation. It was great. # #Disposhan has the fiscal year leading to Azar and has been good for the last two seasons and made 9 and 10 Tomans, a total of 19 Tomans, 65% more than last year PE ~ 6.7. And the price of 246 USD ▫️ The profit is fully operational, and of course we are still concerned about the high demand collection, which leads to the financial cost, and for example, spring has wiped out about half of the profits! ✅ #Heifice and Continue Reading Good Agriculture Group. Spring 14 Tomans, 53% more than last year PE ~ 5.8, price 346 USD # #Dana made an interesting and good report of 74 USD, 348% more than spring and 119% more than last year PE ~ 1.9, price 226 USD It was very good and interestingly it was operational and insurance activities! Opportunity we will examine more later. # #Vine and Spring 24 Tomans, equivalent to 144% of last year's total profit PE ~ 3.7, price 160 USD ▫️ Last year, the spring of 17 Tomans identified the profit, but with the summer losses the overall profit declined. Risk of predicting company profit is high # #Chafst was good. The fiscal year ends in September and has made 21, 35 and 51 Tomans, respectively, a total of 107 USD, 15% more than last year PE ~ 5.6. And the price of 944 USD ✅ Respect for #Fasbazar should be a hat that has been able to make his own industry in this situation. The last two seasons made 152 and 365 Tomans, a total of 517 USD, 4% less than last year PE ~ 3.5. And the price of 3375 USD ——————————————————— # #Betheran was good and spring 17 Tomans, equivalent to 38% of last year's total profit PE ~ 3.1, priced at 186 USD # #Sarsas has a fiscal year leading to September and has made 21, 26 and 40 Tomans, respectively, a total of 87 USD, 200% more than last year PE ~ 8. And priced at 1585 USD The major profit of the company usually comes from summer and white. Spring sales are good, but the cost of the cost is also significant, mainly from other costs that your company does not have a coherent procedure to identify. The report was good and it could be better. # #Zaghiam was also good and spring 22 Tomans, 38% more than last year PE ~ 6.1, price 346 USD Operational profit has grown by 30% and improves profits by selling more livestock. # #Hijra was good and spring was 10 Tomans, 12% more than last year PE ~ 6, price 255 USD # #Saveh was not as good as the rest of the group. Spring 31 Tomans Construction, 29% More than last year PE 7.4, Price 908 Tomans # #Qazvin Spring 12 Tomans, 64% more than last year PE 5.1, price of 591 USD # #Volk was good and spring 14 Tomans, 40% more than last year PE 6.9, price 281 USD 🔳 #The fiscal year ends in September and has made 10, 11 and 10 Tomans in the last three seasons, a total of 46 Tomans, 17% more than last year PE 6.2. And the price of 272 USD # #Hussein was ordinary and made up to 63 Tomans, 14% less than last year PE 5.5, priced 1479 USD and, of course, with the dividend of the PE assembly. # #The goods were good and spring 30 Tomans, 94% more than last year PE ~ 7, price 869 USD # #Ketoka was good and spring was 16 Tomans, 97% more than last year PE 11.1, price 394 USD

بورس طارم
The drug made 2.5 times as much as last spring This year's spring report shows that the company has managed to increase gross profit by 5 % as sales increased by 5 % compared to the same period last year. The company, which had announced 2 billion tomans last spring, has increased this number to 5 billion tomans this year. The total net profit was 2 billion tomans. According to the comparison between the June and spring sales report of this year and the same period last year and the winter season, symbols #Defra #Drug #Dalber #Caspian #Dabor #Danco #Danco and #Damidid, show the greatest monthly sales increase compared to their past times. #Medication #Medication 📱 @fardaname

بورس طارم
ان Disagreevi was revived Zahravi's pharmacy, which had spent many years in 1 and 2, reported 2 billion tomans and 2 billion tomans of net profit last year. December this year has announced 2 billion tomans of profits, which is a 5 percent increase over the same period last year. According to the comparison between the June and spring sales report of this year and the same period last year and the winter season, symbols #Defra #Drug #Dalber #Caspian #Dabor #Danco #Danco and #Damidid, show the greatest monthly sales increase compared to their past times. #Delimravi #Pharmaceutical 📱 @fardaname

بورس طارم
#Medication #Report_1404 *Distribution of the Disanko Disanko Disan Defara Defra Deller Qasim Hijra A look at the 12 drug symbols that have released the Spring 1404 report is promising. @validhelalat

•𝑩𝑶𝑼𝑹𝑺~ 𝑺𝑲𝒀•
# #Disagne was revived Zahravi's pharmacy, which had spent many years in 1 and 2, reported 2 billion tomans and 2 billion tomans of net profit last year. December this year has announced 2 billion tomans of profits, which is a 5 percent increase over the same period last year. According to a comparison between June and spring sales report and the same period last year and winter, the symbols of #Defra #Drug #Dulbar #Caspian #Dabor #Danco #Danco and #Dabid, show the greatest monthly sales increase compared to their past times. #Delimravi #Pharmaceutical 🌀@Bours_Sky
افزایش سرمایه دسبحان
تاریخ | نوع افزایش سرمایه | درصد افزایش سرمایه |
---|---|---|
1403/11/13 | آورده نقدی | 47% |
1403/09/28 | سود انباشته | 28% |
1402/06/01 | سود انباشته | 47% |
1401/09/22 | سود انباشته | 49% |
1400/10/12 | آورده نقدی | 59% |
تقسیم سود دسبحان
تاریخ | مقدار سود | درصد تقسیم سود |
---|---|---|
1403/12/25 | 150 | 35.29% |
1403/02/30 | 590 | 65.48% |
1402/03/07 | 550 | 52.18% |
1401/03/09 | 350 | 47.11% |
1400/03/03 | 1680 | 89.79% |
مجامع دسبحان
تاریخ | نوع مجامع |
---|---|
1404/04/28 | آگهی دعوت به مجمع عمومی فوق العاده دوره 12 ماهه منتهی به 1404/09/30 |
1403/12/25 | آگهی دعوت به مجمع عمومی عادی سالیانه دوره 9 ماهه منتهی به 1403/09/30 |
1403/09/28 | آگهی دعوت به مجمع عمومی فوق العاده دوره 12 ماهه منتهی به 1403/12/30(اصلاحیه) |
1403/09/24 | آگهی دعوت به مجمع عمومی فوق العاده دوره 12 ماهه منتهی به 1403/12/30 |
1403/02/30 | آگهی دعوت به مجمع عمومی عادی سالیانه دوره 12 ماهه منتهی به 1402/12/29 |
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.